Neogen Corporation Total Contract Liability
Neogen Corporation (NEOG) had Total Contract Liability of $3.60 million as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-07-30
- 2026-05-31: Contract with Customer, Liability $3.60M.
- 2026-02-28: Contract with Customer, Liability $3.90M.
- 2025-11-30: Contract with Customer, Liability $3.90M; Contract with Customer, Liability as first filed $3.87M.
- 2025-08-31: Contract with Customer, Liability $5.82M.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2026-05-31 | $3.60M 10-K · filed 2026-07-30 | |
| 2026-02-28 | $3.90M 10-Q · filed 2026-04-09 | |
| 2025-11-30 | $3.90M 10-Q · filed 2026-04-09 | $3.87M 10-Q · filed 2026-01-08 |
| 2025-08-31 | $5.82M 10-Q · filed 2026-01-08 | |
| 2025-05-31 | $5.60M 10-K · filed 2026-07-30 | $5.56M 10-K · filed 2025-07-30 |
| 2025-02-28 | $5.80M 10-Q · filed 2026-04-09 | $5.77M 10-Q · filed 2025-04-09 |
| 2024-11-30 | $5.70M 10-Q · filed 2026-04-09 | $5.65M 10-Q · filed 2025-01-15 |
| 2024-08-31 | $5.63M 10-Q · filed 2026-01-08 | |
| 2024-05-31 | $4.60M 10-K · filed 2026-07-30 | $4.63M 10-Q · filed 2024-10-10 |
| 2024-02-29 | $5.49M 10-Q · filed 2025-04-09 | $0.00 10-Q · filed 2024-04-09 |
| 2023-11-30 | $4.68M 10-Q · filed 2025-04-09 | $0.00 10-Q · filed 2024-01-09 |
| 2023-08-31 | $3.79M 10-Q · filed 2025-01-15 | |
| 2023-05-31 | $4.62M 10-K · filed 2025-07-30 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-10-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |